

VCBeat Health Contact Us

China Healthcare Select

Vertical Industries 

Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory

Home Laekna Therapeutics Inks $527M License Deal with Vasque Bio for PI3Kα Inhibitor LAE118

Laekna Therapeutics Inks $527M License Deal with Vasque Bio for PI3Kα Inhibitor LAE118

Jun 10, 2026 09:31 CST Updated 15:10

Share:

vcbeatglobal@vcbeat.net 

SERVICES

Partnership Development Market Entry Advisory Ecosystem Engagement Advisory

COMPANY

About VCBeat Why VCBeat Contact Us

CHANNELS

China Healthcare Select Insights MNC China Lens Events VB100 GMPC

MORE

PRIVACY VCBEAT CHINA

© 2025 VCBeat. All rights reserved.